Allocation concealment in randomised trials: defending against deciphering.
about
Observational research, randomised trials, and two views of medical scienceCan animal models of disease reliably inform human studies?What makes self-help interventions effective in the management of depressive symptoms? Meta-analysis and meta-regressionBack schools for acute and subacute non-specific low-back painCombined pharmacotherapy and behavioural interventions for smoking cessationAdditional behavioural support as an adjunct to pharmacotherapy for smoking cessationMotivational interviewing for smoking cessationHormonal and intrauterine methods for contraception for women aged 25 years and youngerCorticosteroids for parasitic eosinophilic meningitisCouple and family therapies for post-traumatic stress disorder (PTSD)Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitusOral contraceptives for functional ovarian cystsPsychological therapies for pathological and problem gamblingSkin patch and vaginal ring versus combined oral contraceptives for contraceptionHormonal contraceptives for contraception in overweight or obese womenBehavioral interventions for improving dual-method contraceptive useStrategies for communicating contraceptive effectivenessCombined pharmacotherapy and behavioural interventions for smoking cessationCorticosteroids for parasitic eosinophilic meningitisHormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitusTheory-based interventions for contraception20 µg versus >20 µg estrogen combined oral contraceptives for contraceptionCombination contraceptives: effects on weightProgestin-only contraceptives: effects on weightBehavioral interventions for improving dual-method contraceptive useBehavioral interventions for improving condom use for dual protectionHyperbaric oxygen therapy for treating acute surgical and traumatic woundsCombined oral contraceptive pills for treatment of acneBehavioural interventions as adjuncts to pharmacotherapy for smoking cessationProgestin-only pills for contraceptionImmediate start of hormonal contraceptives for contraceptionCombined oral contraceptive pills for treatment of acneBehavioral interventions for improving condom use for dual protectionHormonal and intrauterine methods for contraception for women aged 25 years and youngerOral contraceptives containing drospirenone for premenstrual syndromeBehavioural interventions as adjuncts to pharmacotherapy for smoking cessationAzithromycin for treating uncomplicated malariaProgestin-only contraceptives: effects on weightHormonal contraceptives for contraception in overweight or obese women
P2860
Q21144655-38C0DD8F-0BE3-440C-92C9-C3B298B6B653Q21563449-EDEB0E63-08F2-4AB0-B8A0-08259CA5A99FQ22251388-DC592E9C-DE69-47CA-A08E-9E282877C63EQ24185866-199B70E0-6068-41CE-9C72-F79D794F27E8Q24186008-A469A7AC-D9D1-4209-99C0-7EE8698D1BF5Q24186545-6A76C056-4379-47E6-9B1D-D2378FA93685Q24187470-716E37F9-331D-4253-A860-92068932C0D8Q24187851-1E71C30B-76EB-412A-8517-58A615948D37Q24188111-FE5ED5C6-A591-40C5-B668-B5B63BD6E85EQ24194172-78496741-93C7-475D-A354-B8C9739124E4Q24194970-164A25E0-03E2-4756-9AB9-A7CFE7D5BD61Q24194982-2754282A-77AE-4B51-A3ED-9DB15BD88A40Q24197476-4447C89C-4E8A-4F3C-B9E3-62CFFF28BD45Q24197649-0DB82B40-8046-4F9C-A303-31E4267C93BDQ24197670-19423B0E-5A27-4D34-A078-815DA8E0EB36Q24197792-08D7DF57-263D-4737-8FEF-53702104BDDFQ24197840-E3BED7D0-2A38-4395-80F5-A38ED7AB20D1Q24198116-BC3F8839-2ADD-4F07-A857-B1C15784E09AQ24198287-DBFEAFDE-8247-4A8B-B770-8FE33948A2A7Q24199074-7434997D-2F61-43AA-8008-78BEAE3819F6Q24200450-E18C58A9-7C73-4EAD-9E40-708D6160F3AEQ24200514-B07F8742-8869-45D1-946C-EDB6C903A073Q24200612-3C8B0C19-9B20-463C-AC38-516D4F06D0A7Q24200949-1C772712-56B2-4F42-B6A6-31938B7655DFQ24201381-8B00E8C8-36BC-42AA-A770-2813B2053D91Q24201454-FB19D489-CB0B-4427-974B-4EACF44FC37BQ24201538-32EB7BEA-3BED-475E-9DC7-2D59AD81690BQ24201777-063F75D1-5B08-4F50-95DE-FFA8233BB5A5Q24201998-23774373-AC50-4210-BD3E-FA2D04ED0293Q24202466-52EBF4C5-E28D-4ED6-906E-9F4C4EF9003BQ24202483-88F79F32-61A3-42F3-8219-BF272A92FFC8Q24202496-9EBF3013-9122-48B1-9B43-18530CDFC1FCQ24202713-FE29CC16-F864-4DBD-8C21-1A7B58E528C6Q24202893-52AF8865-6125-4557-B2DF-2AA3CDE5F987Q24202930-DE260A23-7CF6-41CF-ABA6-A96D48DC5735Q24203717-7803E911-0D0C-45DE-AB73-30F4F837F0F9Q24203802-60752112-3F2F-469D-B23F-E4608F23C049Q24234168-5672D625-2738-4755-8EC6-A807460E3B49Q24234233-81B081B3-445A-4425-A915-8A7DA62DC690Q24234234-89193349-284A-43A4-9B47-6E00A0F0DDFF
P2860
Allocation concealment in randomised trials: defending against deciphering.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Allocation concealment in randomised trials: defending against deciphering.
@ast
Allocation concealment in randomised trials: defending against deciphering.
@en
Allocation concealment in randomised trials: defending against deciphering.
@nl
type
label
Allocation concealment in randomised trials: defending against deciphering.
@ast
Allocation concealment in randomised trials: defending against deciphering.
@en
Allocation concealment in randomised trials: defending against deciphering.
@nl
prefLabel
Allocation concealment in randomised trials: defending against deciphering.
@ast
Allocation concealment in randomised trials: defending against deciphering.
@en
Allocation concealment in randomised trials: defending against deciphering.
@nl
P1433
P1476
Allocation concealment in randomised trials: defending against deciphering.
@en
P2093
Kenneth F Schulz
P304
P356
10.1016/S0140-6736(02)07750-4
P407
P50
P577
2002-02-01T00:00:00Z